How should a pregnant patient with chronic placental abruption be managed, including admission, monitoring, antenatal corticosteroids, magnesium sulfate for neuroprotection, delivery timing based on gestational age and maternal/fetal stability, and postpartum care?

Management of Chronic Placental Abruption

Critical Initial Assessment and Stabilization

Chronic placental abruption requires immediate hospitalization with continuous maternal-fetal monitoring, establishment of large-bore IV access, and activation of massive transfusion protocols without waiting for laboratory confirmation if significant bleeding is present. 1

Immediate Actions Upon Diagnosis

• Establish two large-bore IV lines (≥18 gauge) for rapid fluid and blood product administration 1
• Obtain baseline laboratories: complete blood count, type and crossmatch for 4-6 units, coagulation panel (PT, PTT, fibrinogen), and platelet count 1
• Activate massive transfusion protocol early if active bleeding is present—do not wait for laboratory results as this significantly increases maternal morbidity 1
• Maintain maternal core temperature >36°C because clotting factors function poorly at lower temperatures 1, 2
• Monitor fibrinogen levels closely; declining levels indicate consumption despite normally elevated pregnancy values 1

Maternal Monitoring Protocol

• Continuous vital sign monitoring with pulse oximetry 3
• Serial assessment of vaginal bleeding (visible and concealed hemorrhage) 1
• Twice-weekly laboratory evaluation: hemoglobin, platelet count, liver transaminases, creatinine, coagulation studies 3
• Clinical assessment for signs of disseminated intravascular coagulopathy 4, 5
• Urine output monitoring (target ≥0.5 mL/kg/hour) 1

Fetal Surveillance

• Continuous electronic fetal monitoring for non-reassuring fetal status 3, 5
• Ultrasound assessment of fetal biometry, amniotic fluid volume, and umbilical artery Doppler at diagnosis, then every 2 weeks if initially normal 3
• More frequent Doppler assessment if fetal growth restriction is present 3

Gestational Age-Based Management Algorithm

Before 24 Weeks (Periviable)

• Counsel patient that termination of pregnancy may be required given the limits of viability and high risk of maternal complications 3
• If continuing pregnancy, transfer immediately to a Level III/IV maternal care center with maternal-fetal medicine expertise 3

24 0/7 to 33 6/7 Weeks

Expectant management at a tertiary center with maternal-fetal medicine expertise is appropriate only if both mother and fetus remain stable. 3

• Administer antenatal corticosteroids (betamethasone 12 mg IM q24h × 2 doses or dexamethasone 6 mg IM q12h × 4 doses) for fetal lung maturation 3, 2
• Administer magnesium sulfate for fetal neuroprotection if delivery is anticipated before 32 0/7 weeks (4-6 g IV loading dose, then 1-2 g/hour maintenance) 6
• Magnesium sulfate tocolysis is NOT recommended for placental abruption, as it provides no benefit in pregnancy prolongation and may mask deterioration 7
• Hospitalization is mandatory for active bleeding, with consideration for outpatient management only after complete resolution and confirmed stability 3

34 0/7 to 36 6/7 Weeks

• Continue expectant conservative management if maternal and fetal status remain reassuring 3
• Administer antenatal corticosteroids if not previously given 3, 2
• Maintain twice-weekly laboratory surveillance and continuous readiness for emergent delivery 3

≥37 0/7 Weeks

Proceed to delivery regardless of bleeding status, as the risk of maternal-fetal complications outweighs any benefit of continued pregnancy. 3

Absolute Indications for Immediate Delivery (Any Gestational Age)

Deliver immediately when ANY of the following develop, regardless of gestational age: 3, 1

• Maternal hemodynamic instability (hypotension, tachycardia, shock) 1
• Inability to control blood pressure despite ≥3 classes of antihypertensives 3
• Maternal pulse oximetry <90% 3
• Progressive thrombocytopenia or coagulopathy 3, 1
• Progressive deterioration in liver function or renal function (rising creatinine) 3
• Ongoing severe neurological symptoms (intractable headache, visual scotomata, eclampsia) 3
• Non-reassuring fetal status (category III fetal heart tracing, reversed end-diastolic flow on umbilical artery Doppler, or stillbirth) 3, 5
• Pulmonary edema 3

Mode of Delivery Decision

Vaginal Delivery Preferred When:

• Fetal demise has occurred 1, 4
• Maternal and fetal status are reassuring at term with stable vital signs 4, 5
• Cervix is favorable and delivery is anticipated to be rapid 4, 5

Cesarean Delivery Indicated When:

• Maternal hemodynamic instability requiring rapid delivery 1
• Non-reassuring fetal status 1, 4, 5
• Failed induction or prolonged labor with ongoing bleeding 4, 5
• Placenta accreta spectrum is suspected or confirmed 3, 1

Hemorrhage Management Protocol

Massive Transfusion Strategy

Transfuse blood products in a fixed 1:1:1 ratio of packed red blood cells : fresh frozen plasma : platelets when massive hemorrhage occurs. 1, 2

• Activate massive transfusion protocol at first sign of hemodynamic instability 1
• Consider tranexamic acid (1 g IV over 10 minutes, then 1 g over 8 hours) to reduce blood loss 1
• Re-dose prophylactic antibiotics if blood loss exceeds 1,500 mL 2
• Target fibrinogen >200 mg/dL; consider cryoprecipitate if <200 mg/dL 1

Surgical Hemorrhage Control Techniques

If hemorrhage is uncontrolled after delivery: 1

• Uterine compression sutures (B-Lynch, Cho, or Hayman)
• Hypogastric artery ligation
• Pelvic packing with laparotomy pads
• Interventional radiology embolization (if patient is stable enough for transfer)
• Cesarean hysterectomy as definitive management

Intraoperative Considerations

If Placenta Accreta Spectrum Encountered Unexpectedly

If abnormal placental adherence is discovered at delivery, leave the placenta in situ and proceed to cesarean hysterectomy if hemorrhage is uncontrolled. 3, 1

• Do NOT attempt manual placental removal, as this precipitates catastrophic hemorrhage 3, 1
• If the uterus is already open, rapidly close the uterine incision and mobilize appropriate resources 3
• Alert anesthesia team and consider conversion to general anesthesia 1
• Bring cell salvage technology to the operating room if available 1
• If optimal surgical expertise is unavailable and patient is stable, consider temporary abdominal packing, tranexamic acid infusion, and transfer to a tertiary center 3, 1

Anesthetic Management

• General anesthesia with endotracheal intubation is preferred for hemodynamically unstable patients with active hemorrhage 1
• Neuraxial techniques (spinal or epidural) may be considered only in hemodynamically stable patients with minimal bleeding 1
• Administer non-particulate antacids before operative procedures to reduce aspiration risk 1

Postpartum Management

Intensive Care Monitoring

Transfer to ICU for severe abruption cases given risks of ongoing bleeding, fluid overload, renal failure, liver failure, and disseminated intravascular coagulopathy. 3, 1, 2

• Maintain low threshold for reoperation if ongoing bleeding is suspected 3, 1, 2
• Monitor for renal failure, liver failure, infection, unrecognized ureteral/bladder/bowel injury, and pulmonary edema 3, 1
• Maintain vigilance for Sheehan syndrome (postpartum pituitary necrosis) given potential for hypoperfusion 3, 1
• Close hemodynamic monitoring of volume status, urine output, and blood loss 1, 2

Follow-Up Care

• Ensure adequate iron supplementation if significant blood loss occurred 3, 2
• Follow-up hemoglobin levels at 1-2 weeks postpartum 2
• Counsel regarding 4.9- to 7.1-fold increased risk of recurrent abruption in future pregnancies 8
• In subsequent pregnancies, initiate special surveillance 6-12 weeks prior to the gestational age of the initial abruption 8

Critical Pitfalls to Avoid

• Never delay transfusion protocols while waiting for laboratory confirmation—treat based on clinical presentation 1
• Never perform digital cervical examination until placenta previa has been excluded by ultrasound 2
• Never attempt manual placental removal if abnormal adherence is suspected 3, 1
• Never use magnesium sulfate as a tocolytic for placental abruption—it provides no benefit 7
• Never discharge a bleeding patient with placental abruption for outpatient management 3
• Never rely solely on ultrasound to diagnose or exclude abruption—diagnosis is primarily clinical 4, 5